Ulm, Germany

Biogenerix Ag


USPTO Granted Patents = 9

% Expired Patents = 77.8



Forward Citations = 129

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Shawn DeFrees (4 out of 61 patents)

silverMedal Walter Hinderer (3 out of 7 patents)

bronzeMedal Christian Scheckermann (2 out of 5 patents)

4.  Karl Frank Johnson (2 out of 14 patents)

5.  Heinz Lubenau (1 out of 15 patents)

6.  Henrik Clausen (1 out of 52 patents)

7.  Stefan Arnold (1 out of 6 patents)

8.  David A Zopf (1 out of 44 patents)

9.  Zhi-Guang Wang (1 out of 6 patents)

10.  Kyle Kinealy (1 out of 2 patents)

11.  Nanni Jelinek (1 out of 1 patent)

12.  Marc F Schwartz (1 out of 3 patents)

13.  Aliakbar Mobasseri (1 out of 2 patents)

14.  Xiaomei Bai (1 out of 1 patent)

15.  David Jennings Hakes (34 patents)


9 patents:

Company Overview
Biogenerix Ag is a leading biotechnology company that specializes in the development and manufacturing of innovative biopharmaceuticals. With a focus on research and development, Biogenerix Ag strives to bring new and advanced treatments to patients worldwide. The company is committed to improving the quality of life for individuals suffering from various diseases and medical conditions through its cutting-edge products.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#14 in Ulm

#4,072 in Germany

Ulm, DE
Ulm, Germany
Forward Citations = 129

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biogenerix Ag. Retrieved from https://idiyas.com/company/biogenerix-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…